<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wei M</submitter><funding>National Natural Science Foundation of China</funding><funding>Southwest Minzu University</funding><pagination>8980-8987</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8928518</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(10)</volume><pubmed_abstract>A microreactor (MR) with a vaporization microchamber and a sinusoidal wave microchannel was fabricated to synthesize 2-cyanopyrazine (CP) directly with an aqueous 2-methylpyrazine (MP) solution. A continuous-flow process with high space-time yield was achieved under the premise of strong exothermality of this ammoxidation reaction. The vanadium metal oxide catalysts with four different supports (α-Al&lt;sub>2&lt;/sub>O&lt;sub>3&lt;/sub>, γ-Al&lt;sub>2&lt;/sub>O&lt;sub>3&lt;/sub>, ZSM-5(50), ZSM-5(80)) were evaluated by simply stacking in the wave microchannel from 350 to 540 °C. The process parameters (temperature, reactant ratio, and size of catalysts) were optimized with the selected CrVPO/γ-Al&lt;sub>2&lt;/sub>O&lt;sub>3&lt;/sub> catalyst, and an optimal ammoxidation process with MP conversion (&lt;i>X&lt;/i> &lt;sub>MP&lt;/sub>) of 71.5% and CP selectivity (&lt;i>S&lt;/i> &lt;sub>CP&lt;/sub>) of 93.7% was obtained by a volume space velocity (GHSV) of 13 081 h&lt;sup>-1&lt;/sup> at 480 °C. Correspondingly, the space-time yield of CP (STY&lt;sub>CP&lt;/sub>) was 1724-77 082 g&lt;sub>CP&lt;/sub>kg&lt;sub>cat&lt;/sub> &lt;sup>-1&lt;/sup>h&lt;sup>-1&lt;/sup>, which was the highest value ever reported for this reaction. Meanwhile, the ammoxidation reaction showed a great continuous-synthesis stability of 50-h running in the microreactor with the CP yield (&lt;i>Y&lt;/i> &lt;sub>CP&lt;/sub>) remaining 56%-68%.</pubmed_abstract><journal>ACS omega</journal><pubmed_title>Continuous-Flow Ammoxidation of 2-Methylpyrazine to 2-Cyanopyrazine with High Space-Time Yield in a Microreactor.</pubmed_title><pmcid>PMC8928518</pmcid><funding_grant_id>21406183</funding_grant_id><funding_grant_id>CX2020SZ15</funding_grant_id><pubmed_authors>Wei M</pubmed_authors><pubmed_authors>Ma H</pubmed_authors><pubmed_authors>Ma Z</pubmed_authors><pubmed_authors>Chen X</pubmed_authors><pubmed_authors>Lu Q</pubmed_authors><pubmed_authors>Ruan D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Continuous-Flow Ammoxidation of 2-Methylpyrazine to 2-Cyanopyrazine with High Space-Time Yield in a Microreactor.</name><description>A microreactor (MR) with a vaporization microchamber and a sinusoidal wave microchannel was fabricated to synthesize 2-cyanopyrazine (CP) directly with an aqueous 2-methylpyrazine (MP) solution. A continuous-flow process with high space-time yield was achieved under the premise of strong exothermality of this ammoxidation reaction. The vanadium metal oxide catalysts with four different supports (α-Al&lt;sub>2&lt;/sub>O&lt;sub>3&lt;/sub>, γ-Al&lt;sub>2&lt;/sub>O&lt;sub>3&lt;/sub>, ZSM-5(50), ZSM-5(80)) were evaluated by simply stacking in the wave microchannel from 350 to 540 °C. The process parameters (temperature, reactant ratio, and size of catalysts) were optimized with the selected CrVPO/γ-Al&lt;sub>2&lt;/sub>O&lt;sub>3&lt;/sub> catalyst, and an optimal ammoxidation process with MP conversion (&lt;i>X&lt;/i> &lt;sub>MP&lt;/sub>) of 71.5% and CP selectivity (&lt;i>S&lt;/i> &lt;sub>CP&lt;/sub>) of 93.7% was obtained by a volume space velocity (GHSV) of 13 081 h&lt;sup>-1&lt;/sup> at 480 °C. Correspondingly, the space-time yield of CP (STY&lt;sub>CP&lt;/sub>) was 1724-77 082 g&lt;sub>CP&lt;/sub>kg&lt;sub>cat&lt;/sub> &lt;sup>-1&lt;/sup>h&lt;sup>-1&lt;/sup>, which was the highest value ever reported for this reaction. Meanwhile, the ammoxidation reaction showed a great continuous-synthesis stability of 50-h running in the microreactor with the CP yield (&lt;i>Y&lt;/i> &lt;sub>CP&lt;/sub>) remaining 56%-68%.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2025-04-18T14:14:37.17Z</modification><creation>2025-04-04T20:23:19.203Z</creation></dates><accession>S-EPMC8928518</accession><cross_references><pubmed>35309436</pubmed><doi>10.1021/acsomega.2c00039</doi></cross_references></HashMap>